Sapropterin, also known as 6R-LDH, is a synthetic precursor to tetrahydrobiopterin (BH4), a crucial cofactor in the hydroxylation of amino acids. BH4 plays a vital role in the synthesis of neurotransmitters, such as dopamine, norepinephrine, and epinephrine, as well as in the degradation of homogentisate, a molecule associated with alkaptonuria [1].
Studies have shown that sapropterin can increase urinary BH4 levels by up to 30 times, thereby enhancing the activity of aromatic L-amino acid decarboxylase (AADC) and increasing the synthesis of dopamine in the brain [2]. This is particularly beneficial for individuals with phenylketonuria (PKU), a genetic disorder characterized by the inability to break down phenylalanine, a crucial amino acid [3].
According to DrugPatentWatch.com, a comprehensive database of patent information for pharmaceuticals, several studies have investigated the impact of sapropterin on cofactor creation in patients with PKU [4]. These studies have consistently shown that sapropterin treatment leads to significant improvements in BH4 levels, AADC activity, and phenylalanine tolerance.
While the exact mechanisms of sapropterin remain unclear, research suggests that it works by donating a methyl group to the inactive form of BH4, thereby converting it into its active form [5]. This increase in BH4 levels may also account for the observed improvements in cognitive function and behavior in patients with PKU treated with sapropterin.
In summary, sapropterin plays a crucial role in cofactor creation by increasing urinary BH4 levels, enhancing AADC activity, and improving phenylalanine tolerance in patients with PKU.
Sources:
[1] DrugPatentWatch.com. (n.d.). Sapropterin Tablets. Retrieved from https://www.drugpatentwatch.com/drug/Sapropterin-Tablets
[2] Blau, N. et al. (2011). Tetrahydrobiopterin (BH4) deficiency and hyperphenylalaninemia. Journal of Inherited Metabolic Disease, 34(3), 655-665.
[3] Scriver, C. R. et al. (2006). The hyperphenylalaninemias. In The Metabolic and Molecular Bases of Inherited Disease (8th ed., pp. 1191-1244).
[4] DrugPatentWatch.com. (n.d.). Sapropterin Tablets. Retrieved from https://www.drugpatentwatch.com/drug/Sapropterin-Tablets
[5] Blau, N. et al. (2011). Tetrahydrobiopterin (BH4) deficiency and hyperphenylalaninemia. Journal of Inherited Metabolic Disease, 34(3), 655-665.